| | |
| Clinical data | |
|---|---|
| Other names | TFMCPP; meta-Trifluoromethyl-para-chlorophenylpiperazine; PAL-179; PAL179 |
| Drug class | Selective partial serotonin releasing agent |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H12ClF3N2 |
| Molar mass | 264.68 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3-Trifluoromethyl-4-chlorophenylpiperazine (TFMCPP; code name PAL-179), or meta-trifluoromethyl-para-chlorophenylpiperazine, is a monoamine releasing agent of the phenylpiperazine family. [1] It acts specifically as a selective partial serotonin releasing agent, with an EC50 of 33 nM and an Emax of 66%. [1] The drug was inactive as a releasing agent of dopamine or norepinephrine (EC50 >10,000 nM). [1] Its possible activity at serotonin receptors was not reported. [1] TFMCPP was first described in the scientific literature by 2012. [1]